Answers are grounded in this paper and cite their sources.
Prospective cross-sectional study examines resistance genes in uropathogens, indicating a need for better treatment strategies.
Urinary tract infections (UTIs) represent a major public health challenge worldwide, accounting for millions of outpatient consultations and substantial healthcare expenditure annually. In this prospective cross-sectional investigation conducted from February 2019 to January 2020 at a tertiary-care hospital in Islamabad, Pakistan, we examined the etiological agents of UTI, their antimicrobial susceptibility profiles, and the occurrence of the aminoglycoside resistance genes aac(6’)-Ib-cr and the β-lactam resistance genes blaTEM among 503 patients with suspected UTI. Culture-confirmed UTI was established in 127 patients (25.2%; 95% CI 21.5–29.3%), with markedly higher prevalence in females (33.6%) than males (16.8%; P < 0.001). Of these, 16 (12.6%) yielded polymicrobial growth. Gram-negative bacilli predominated (110/127 isolates, 86.6%), led by Escherichia coli (91/127, 71.7%), followed by Klebsiella spp. (9/127, 7.1%), Proteus spp. (6/127, 4.7%), and Pseudomonas spp. (4/127, 3.1%). Among Gram-negative isolates, susceptibility was highest to cefepime (75.8%) and cefoxitin (68.1%), whereas resistance exceeded 65% against gentamicin, ampicillin, ceftriaxone, and ciprofloxacin, with 68.1% classified as multidrug-resistant. Gram-positive isolates retained full susceptibility to imipenem and vancomycin. These findings underscore the urgent requirement for routine culture-guided therapy, enhanced antimicrobial stewardship, and continuous local surveillance to mitigate the emergence of untreatable uropathogens.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: